Literature DB >> 20527430

[Multicenter national Polish population health status tests--WOBASZ project with defined problems and treatment goals].

Grazyna Broda1, Stefan Rywik.   

Abstract

Mesh:

Year:  2005        PMID: 20527430

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  15 in total

1.  MTHFR 677T is a strong determinant of the degree of hearing loss among Polish males with postlingual sensorineural hearing impairment.

Authors:  Agnieszka Pollak; Malgorzata Mueller-Malesinska; Urszula Lechowicz; Agata Skorka; Lech Korniszewski; Agnieszka Sobczyk-Kopciol; Anna Waskiewicz; Grazyna Broda; Katarzyna Iwanicka-Pronicka; Monika Oldak; Henryk Skarzynski; Rafał Płoski
Journal:  DNA Cell Biol       Date:  2012-03-16       Impact factor: 3.311

2.  Variants of the lamin A/C (LMNA) gene in non-valvular atrial fibrillation patients: a possible pathogenic role of the Thr528Met mutation.

Authors:  Michal Saj; Rafal Dabrowski; Sarah Labib; Agnieszka Jankowska; Malgorzata Szperl; Grazyna Broda; Hanna Szwed; Frederique Tesson; Zofia T Bilinska; Rafal Ploski
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.074

3.  DISC1 as a Possible Genetic Contribution to Opioid Dependence in a Polish Sample.

Authors:  Sylwia Fudalej; Andrzej Jakubczyk; Maciej Kopera; Jerzy Piwonski; Wojciech Bielecki; Wojciech Drygas; Krystyna Wasilewska; Mark Ilgen; Amy Bohnert; Kristen Barry; Rafał Płoski; Frederic C Blow; Marcin Wojnar
Journal:  J Stud Alcohol Drugs       Date:  2016-03       Impact factor: 2.582

4.  Dietary antioxidant capacity of the patients with cardiovascular disease in a cross-sectional study.

Authors:  Małgorzata E Zujko; Anna M Witkowska; Anna Waśkiewicz; Walerian Piotrowski; Katarzyna M Terlikowska
Journal:  Nutr J       Date:  2015-03-15       Impact factor: 3.271

5.  Ten-Year Changes in the Prevalence and Socio-Demographic Determinants of Physical Activity among Polish Adults Aged 20 to 74 Years. Results of the National Multicenter Health Surveys WOBASZ (2003-2005) and WOBASZ II (2013-2014).

Authors:  Magdalena Kwaśniewska; Małgorzata Pikala; Wojciech Bielecki; Elżbieta Dziankowska-Zaborszczyk; Ewa Rębowska; Krystyna Kozakiewicz; Andrzej Pająk; Jerzy Piwoński; Andrzej Tykarski; Tomasz Zdrojewski; Wojciech Drygas
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

6.  LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.

Authors:  Michal Saj; Zofia T Bilinska; Agnieszka Tarnowska; Agnieszka Sioma; Pierrette Bolongo; Malgorzata Sobieszczanska-Malek; Ewa Michalak; Dorota Golen; Lukasz Mazurkiewicz; Lukasz Malek; Ewa Walczak; Anna Fidzianska; Jacek Grzybowski; Andrzej Przybylski; Tomasz Zielinski; Jerzy Korewicki; Frederique Tesson; Rafal Ploski
Journal:  BMC Med Genet       Date:  2013-05-23       Impact factor: 2.103

7.  Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study.

Authors:  Piotr Bandosz; Martin O'Flaherty; Wojciech Drygas; Marcin Rutkowski; Jacek Koziarek; Bogdan Wyrzykowski; Kathleen Bennett; Tomasz Zdrojewski; Simon Capewell
Journal:  BMJ       Date:  2012-01-25

8.  Comparison of Various Databases for Estimation of Dietary Polyphenol Intake in the Population of Polish Adults.

Authors:  Anna M Witkowska; Małgorzata E Zujko; Anna Waśkiewicz; Katarzyna M Terlikowska; Walerian Piotrowski
Journal:  Nutrients       Date:  2015-11-11       Impact factor: 5.717

9.  Genetic polymorphism of human Y chromosome and risk factors for cardiovascular diseases: a study in WOBASZ cohort.

Authors:  Grażyna Kostrzewa; Grażyna Broda; Magdalena Konarzewska; Paweł Krajewki; Rafał Płoski
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

Review 10.  The risk factors and prevention of cardiovascular disease: the importance of electrocardiogram in the diagnosis and treatment of acute coronary syndrome.

Authors:  Anna Rosiek; Krzysztof Leksowski
Journal:  Ther Clin Risk Manag       Date:  2016-08-08       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.